Sign in / Join Now
ETFs & Funds
) Conference Call Provides More than Positive Financial Results
Add a reply...
Latest StockTalks »
people get ISCO breaking news and analysis by email alert.
Get email alerts on ISCO »
International Stem Cell Corp.
Get latest price
From other sites
International Stem Cell Corporation Receives Approval To Start Second Patient Cohort In Clinical Trial For Parkinson's Disease
at TheStreet (May 9, 2017)
International Stem Cell Corporation To Present Results Of Neural Stem Cell Transplantation For Parkinson's Disease At The ASGCT 2017 Annual Meeting
at TheStreet (May 4, 2017)
International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial
at TheStreet (Apr 25, 2017)
International Stem Cell Corporation Announces 2016 Fourth Quarter And Year-End Results
at TheStreet (Apr 5, 2017)
International Stem Cell Corporation Announces Third Patient With Parkinson's Disease In Phase I Clinical Trial
at TheStreet (Feb 28, 2017)